Kineticos Life Sciences

Kineticos Life Sciences is a growth and venture investor with a vision to disrupt the life sciences industry by improving patient outcomes. Founded in 2012 and headquartered in the United States, the company is dedicated to supporting startups striving to transform drug development, disease diagnosis, and patient treatment. Kineticos focuses on addressing significant unmet medical needs in the biopharma sector across various areas such as contract services, manufacturing, equipment, and therapeutic companies. The company's investment portfolio encompasses firms leveraging disruptive technologies including cell and gene therapy, gene editing, and mRNA/RNAi, which are revolutionizing the practice of medicine. Kineticos' ultimate goal is to contribute to a world without cancer, rare and neurodegenerative diseases, and antimicrobial resistance. As part of its mission to drive innovation, Kineticos actively seeks out and invests in life science companies striving to make a meaningful impact. To learn more about Kineticos and its diverse capabilities, interested parties can visit their official website at www.kineticos.com. With its focus on disruptive technologies and commitment to addressing critical medical needs, Kineticos stands out as a promising player in the life sciences investment landscape.